Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 3 (2007), Issue 2 (February)

1. Repeated measures analyses of dose timing of antiretroviral medication and its relationship to HIV virologic outcomes.
   Stat Med, 26(5): 991-1007. [Abstract] [Full-text]
2. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study.
   Clin Infect Dis, 44(5): 646-56. [Abstract] [Full-text]
3. Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after liver transplantation.
   J Hepatol, 46(3): 459-65. [Abstract] [Full-text]
4. Fibrosis progression in hepatitis C positive liver recipients after sustained virologic response to antiviral combination therapy (interferon-ribavirin therapy).
   Transplantation, 83(3): 351-3. [Abstract] [Full-text]
5. Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin.
   J Acquir Immune Defic Syndr, 44(2): 174-8. [Abstract] [Full-text]
6. Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy.
   J Acquir Immune Defic Syndr, 44(2): 159-66. [Abstract] [Full-text]
7. Development of hepatocellular carcinoma in patients with chronic hepatitis C who had a sustained virological response to interferon therapy: a multicenter, retrospective cohort study of 1124 patients.
   Liver Int, 27(2): 186-91. [Abstract] [Full-text]
8. Baseline resistance to nucleoside reverse transcriptase inhibitors fails to predict virologic response to combination therapy in children (PACTG 338).
   AIDS Res Ther, 4: 2. [Abstract] [Full-text]
9. Pretreatment factors associated with 3-year (144-week) virologic and immunologic responses to potent antiretroviral therapy.
   J Acquir Immune Defic Syndr, 44(3): 268-77. [Abstract] [Full-text]
10. Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin.
    Scand J Gastroenterol, 42(2): 247-55. [Abstract] [Full-text]

© 2005-2008 Virology Research Today. All Rights Reserved.